Press release
WHIM Syndrome Market Size Analysis, Growth Opportunities, Pipeline Development Activities, Emerging Therapies, and Epidemiology Forecast | Key Companies - NIAID, X4 Pharmaceuticals
DelveInsight's "WHIM Syndrome Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the WHIM Syndrome, historical and forecasted epidemiology as well as the WHIM Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.Some of the key facts of the WHIM Syndrome Market Report: https://www.delveinsight.com/report-store/whim-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
The WHIM syndrome market size was estimated at USD 8 million in 2021 and is anticipated to grow with a significant CAGR during the study period, 2019-2032
According to the National Organization for Rare Disorders (NORD, 2022), WHIM syndrome is an extremely rare disease, with about 100 cases reported in the various medical literature
In 2021, the total prevalent cases of WHIM Syndrome were the highest in the US, with around 70 cases, and lowest in Spain, with around 10 cases.
There were approximately 30 males and 40 females affected by WHIM Syndrome in the United States in 2021, and it is estimated that the prevalence will increase and reach up to 50 males and 75 females by 2032.
WHIM syndrome epidemiology based on gender states that males and females contributed approximately 30 and 45 cases in 2021 in EU5
Among EU5 countries, Germany had the highest number of prevalent cases of WHIM Syndrome (Around 20 cases) in 2021.
According to French Severe Chronic Neutropenia Registry, the incidence of WHIM syndrome was calculated as 0.23 per million births (Cohen et al., 2012).
Request a sample for the WHIM Syndrome Market Report https://www.delveinsight.com/sample-request/whim-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Key benefits of the WHIM Syndrome Market report:
WHIM Syndrome market report covers a descriptive overview and comprehensive insight of the WHIM Syndrome Epidemiology and WHIM Syndrome market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
The WHIM Syndrome market report provides insights on the current and emerging therapies.
WHIM Syndrome market report provides a global historical and forecasted market covering drug outreach in 7MM.
The WHIM Syndrome market report offers an edge to help develop business strategies by understanding trends shaping and driving the WHIM Syndrome market.
Got queries? Click here to know more about the WHIM Syndrome Pipeline Report, click here: https://www.delveinsight.com/sample-request/whim-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
WHIM Syndrome Overview
WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome is an ultra-rare and difficult-to-diagnose primary immunodeficiency disease. In almost all patients of WHIM syndrome, the disease is caused by "gain-of-function" mutations in the single gene that encodes for the CXCR4 receptor.
WHIM syndrome is a congenital immune deficiency with characteristic clinical features that include: susceptibility to human papillomavirus (HPV) infection-induced warts, condyloma acuminata, and carcinomas; neutropenia, B cell lymphopenia, and hypogammaglobulinemia related recurrent infections; and bone marrow myelokathexis characterized by myeloid hyperplasia and apoptosis. WHIM syndrome is diagnosed by clinical findings like neutropenia, recurrent infections, warts, lymphopenia, bone marrow biopsy (myelokathexis), and CXCR4 gene mutation.
WHIM Syndrome Symptoms
The WHIM syndrome symptoms include -
Body Fatigue
Headaches
Pain in the muscles
Difficulty in body movements due to joints pain
Epidemiology Segmentation of WHIM Syndrome:
Prevalent Cases of WHIM Syndrome in the 7MM [2019-2032]
Age-Specific Cases of WHIM Syndrome in the 7MM [2019-2032]
Gender-Specific Cases of WHIM Syndrome in the 7MM [2019-2032]
Diagnosed and Treated Cases of WHIM Syndrome in the 7MM [2019-2032]
WHIM Syndrome Market
The dynamics of the WHIM Syndrome market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as Mavorixafor, X4P-001, and others during the forecasted period 2019-2032.
Learn more by requesting for sample @ WHIM Syndrome Treatment assessment https://www.delveinsight.com/sample-request/whim-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
WHIM Syndrome Therapies
Mavorixafor
X4P-001
Plerixafor
G-CSF
WHIM Syndrome Key Companies
NIAID
X4 Pharmaceuticals
Table of Contents
1. WHIM Syndrome Market Report Introduction
2. Executive Summary for WHIM Syndrome
3. SWOT analysis of WHIM Syndrome
4. WHIM Syndrome Patient Share (%) Overview at a Glance
5. WHIM Syndrome Market Overview at a Glance
6. WHIM Syndrome Disease Background and Overview
7. WHIM Syndrome Epidemiology and Patient Population
8. Country-Specific Patient Population of WHIM Syndrome
9. WHIM Syndrome Current Treatment and Medical Practices
10. WHIM Syndrome Unmet Needs
11. WHIM Syndrome Emerging Therapies
12. WHIM Syndrome Market Outlook
13. Country-Wise WHIM Syndrome Market Analysis (2019-2032)
14. WHIM Syndrome Market Access and Reimbursement of Therapies
15. WHIM Syndrome Market drivers
16. WHIM Syndrome Market barriers
17. WHIM Syndrome Appendix
18. WHIM Syndrome Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Click here to read more about WHIM Syndrome Market Outlook 2032 https://www.delveinsight.com/sample-request/whim-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Related Reports:
WHIM Syndrome Pipeline https://www.delveinsight.com/report-store/whim-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"WHIM Syndrome Pipeline Insight, 2022" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the WHIM Syndrome market. A detailed picture of the WHIM Syndrome pipeline landscape is provided, which includes the disease overview and WHIM Syndrome treatment guidelines.
WHIM Syndrome Epidemiology https://www.delveinsight.com/report-store/whim-syndrome-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'WHIM Syndrome Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted WHIM Syndrome epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Diagnostic Imaging Equipment Market
https://www.delveinsight.com/report-store/diagnostic-imaging-equipment-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Diagnostic Imaging Equipment Market By Product (X-Ray Imaging Systems, Computed Tomography (CT) Scanners, Ultrasound Systems, Magnetic Resonance Imaging (MRI) Systems, Nuclear Imaging Systems, Mammography Systems, And Others), By Application (Cardiology, Oncology, Gastroenterology, Gynecology, And Other Applications), By End-User (Hospitals, Diagnostic Imaging Centres, And Others), by geography is expected to grow at a steady CAGR forecast till 2026 owing to rising technological advancement and increasing prevalence of chronic diseases.
Invasive Candidiasis Market
https://www.delveinsight.com/report-store/invasive-candidiasis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"DelveInsight's 'Invasive Candidiasis Market Insight, Competitive Landscape and Market Forecast, 2027' report delivers an in-depth understanding of Invasive Candidiasis and the historical and forecasted Invasive Candidiasis market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Sialidosis Market
https://www.delveinsight.com/report-store/sialidosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Sialidosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Sialidosis, historical and forecasted epidemiology as well as the Sialidosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Filgrastim Biosimilar Insight
https://www.delveinsight.com/report-store/filgrastim-biosimilar-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's, "Filgrastim Biosimilar Insight, 2022," report provides comprehensive insights about 20+ companies and 20+ marketed and pipeline drugs in the Filgrastim Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and non-clinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Pain Management Devices Market
https://www.delveinsight.com/report-store/pain-management-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Pain Management Devices Market By Type Of Devices (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps [Intrathecal Infusion Pumps and External Infusion Pumps], Ablation Devices [Radiofrequency Ablation Devices And Cryoablation Devices], And Others), By Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others), By Geography is expected to grow at a steady CAGR Forecast till 2027
To know more about our Competitive Services, Click here:
https://www.delveinsight.com/consulting/competitive-intelligence-services?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release WHIM Syndrome Market Size Analysis, Growth Opportunities, Pipeline Development Activities, Emerging Therapies, and Epidemiology Forecast | Key Companies - NIAID, X4 Pharmaceuticals here
News-ID: 2689975 • Views: …
More Releases from DelveInsight Business Research
Global Patient Engagement Solutions Market to reach USD 59,499.28 million by 203 …
According to DelveInsight's analysis, The growth of the patient engagement solutions market is primarily fueled by several major factors, including the increasing burden of chronic conditions such as diabetes and cardiovascular diseases, which require continuous patient involvement and monitoring. The industry is further propelled by the move toward patient-centric healthcare models, ongoing technological innovations, and the introduction of new digital tools and platforms. Moreover, supportive government policies and initiatives aimed…
Global Magnetic Resonance Imaging Devices Market to reach USD 13,553.33 million …
According to DelveInsight's analysis, The growing incidence of chronic illnesses-including heart disease, cancer, and neurological disorders is driving demand for advanced diagnostic methods such as MRI, which provides highly detailed imaging of soft tissues and internal organs. Increasing awareness and a stronger focus on early disease detection are also prompting both patients and healthcare professionals to rely on MRI for faster and more accurate diagnosis. In addition, ongoing technological progress…
Global Microbial Fermentation Technology Market Size was USD 33,956.10 million i …
According to DelveInsight's analysis, The microbial fermentation technology market is experiencing strong growth, largely due to the increasing incidence of chronic illnesses such as cancer and a range of infectious diseases, including HIV, hepatitis B and C, and influenza. The market is also being boosted by the rising need for advanced therapeutic products like cell therapies, monoclonal antibodies, recombinant proteins, and gene therapies. Moreover, progress in synthetic biology and precision…
Global Surgical Robotic System Market to reach USD 29,785.13 million by 2032 at …
According to DelveInsight's analysis, The growing prevalence of chronic illnesses such as cancer, cardiovascular diseases, and orthopedic disorders is driving demand for advanced surgical solutions, which in turn is accelerating the expansion of the surgical robotic systems market. Since many of these conditions require complex, highly precise procedures, robotic-assisted surgery is becoming a preferred option due to its superior precision, less invasive nature, and faster patient recovery. At the same…
More Releases for Syndrome
"Understanding Rett Syndrome: Trends and Advances in the Rett Syndrome Market"
The Rett Syndrome Market, valued at USD 225.02 million in 2022, is anticipated to surge to USD 515.06 million by 2029, reflecting a significant Compound Annual Growth Rate (CAGR) of 10.23% from 2023 to 2029.
Overview of the Rett Syndrome Market:
Rett syndrome, a rare genetic neurological and developmental disorder primarily impacting females, hinders brain development and causes progressive loss of motor skills and language. The market report underscores technological advancements…
MISME Syndrome Market - Navigating Challenges, Embracing Abilities: MISME Syndro …
Newark, New Castle, USA: The "MISME Syndrome Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
MISME Syndrome Market: https://www.growthplusreports.com/report/misme-syndrome-market/8883
This latest report researches the industry structure, sales, revenue,…
Felty Syndrome Market - A Dedicated Approach to Felty Syndrome Care and Empowerm …
Newark, New Castle, USA: The "Felty Syndrome Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Felty Syndrome Market: https://www.growthplusreports.com/report/felty-syndrome-market/8440
This latest report researches the industry structure, sales, revenue,…
MISME Syndrome Market - Transforming Lives: Empowering Recovery from MISME Syndr …
Newark, New Castle, USA - new report, titled MISME Syndrome Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the MISME Syndrome market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global MISME Syndrome market. The report offers an overview of the market, which…
Hepatorenal Syndrome Market - Reimagining Wellness, Redefining Survival: Hepator …
Newark, New Castle, USA - new report, titled Hepatorenal Syndrome Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Hepatorenal Syndrome market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Hepatorenal Syndrome market. The report offers an overview of the market, which…
Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syn …
Global Markets Directs, Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H2 2016, provides an overview of the Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and…
